Skip to main content
. 2020 Nov 12;17(22):8386. doi: 10.3390/ijerph17228386

Figure 14.

Figure 14

Representative drugs of each bicluster and their percentage of use for patients belonging to the bicluster versus the percentage for patients not in the bicluster.